Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
United Industries Corporation currently has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 3 distinct art units. The prosecution involves 3 distinct examiners, with ARK, DARREN W serving as the busiest examiner.
The busiest examiner is currently managing 1 pending office action. This count of 1 pending office action for the busiest examiner shows that the 3 pending office actions are distributed individually among the 3 distinct examiners. The 3 distinct art units involved suggest that the Biotechnology & Pharmaceuticals filings cover multiple technical categories.
Practitioners should monitor the 3 pending office actions across these 3 distinct art units to ensure a cohesive approach. With 3 distinct examiners involved, the company interacts with a different official for every case. The 1 pending office action assigned to ARK, DARREN W is 1 of the 3 pending office actions currently on record. The 3 distinct art units provide a varied examination landscape for the portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARK, DARREN W | 1 | 56.6% | +64.5% |
| CHANDRAKUMAR, NIZAL S | 1 | 72.7% | +18.2% |
| ATKINSON, JOSHUA ALEXANDER | 1 | 51.8% | +27.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19017354 | INSECT TRAP | ARK, DARREN W | 18d overdue |
| 18788348 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | CHANDRAKUMAR, NIZAL S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18181781 | COMPOSITION AND METHOD FOR WEED AND GRASS CONTROL | ATKINSON, JOSHUA ALEXANDER | 121d overdue |
| 19017354 | INSECT TRAP | ARK, DARREN W | 18d overdue |
| 18788348 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | CHANDRAKUMAR, NIZAL S | — |
| Art Unit | Apps |
|---|---|
| 3647 | 1 |
| 1625 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19017354 | INSECT TRAP | ARK, DARREN W | 3647 | §103§112 | Final Rejection | 18d overdue | Pending | Jan 10, 2025 |
| 18788348 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | CHANDRAKUMAR, NIZAL S | 1625 | §103§112Other | Non-Final OA | — | Pending | Jul 30, 2024 |
| 18181781 | COMPOSITION AND METHOD FOR WEED AND GRASS CONTROL | ATKINSON, JOSHUA ALEXANDER | 1612 | §103 | Final Rejection | 121d overdue | Pending | Mar 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUnited Industries Corporation has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Darren W Ark has the most, with 1 of United Industries Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
